Literature DB >> 25277238

Pulmonary sarcoid-like granulomatosis after multiple vaccinations of a long-term surviving patient with metastatic melanoma.

Natacha Bordry1, Carla-Marisa Costa-Nunes1, Laurène Cagnon1, Philippe O Gannon1, Samia Abed-Maillard1, Petra Baumgaertner1, Timothy Murray1, Igor Letovanec2, Romain Lazor3, Hasna Bouchaab4, Nathalie Rufer1, Emanuela Romano4, Olivier Michielin4, Daniel E Speiser5.   

Abstract

Autoimmune side effects are frequent in patients with cancer treated with immune checkpoint-targeting antibodies, but are rare with cancer vaccines. Here, we present a case report on a patient with metastatic melanoma who developed pulmonary sarcoid-like granulomatosis following repetitive vaccinations with peptides and CpG. Despite multiple metastases, including one lesion in the brain, the patient is alive and well more than 13 years after the diagnosis of metastatic disease. The strongly activated tumor-specific CD8(+) T cells showed robust long-term memory and effector functions. It is possible that long-term survival and adverse autoimmune events may become more common for vaccines inducing robust anticancer immune responses as were present in this patient. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25277238     DOI: 10.1158/2326-6066.CIR-14-0143

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  2 in total

1.  Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature.

Authors:  Joshua E Reuss; Paul R Kunk; Anne M Stowman; Alejandro A Gru; Craig L Slingluff; Elizabeth M Gaughan
Journal:  J Immunother Cancer       Date:  2016-12-20       Impact factor: 13.751

2.  Case Report of Extended Survival and Quality of Life in a Melanoma Patient with Multiple Brain Metastases and Review of Literature.

Authors:  William Sperduto; David M King; Yoichi Watanabe; Emil Lou; Paul W Sperduto
Journal:  Cureus       Date:  2017-12-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.